Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 1Duodenal Neoplasms 1Colonic Neoplasms 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Stents × 1 year × Clear all
NCT06274879 2026-05-26

Ablatio

Insel Gruppe AG, University Hospital Bern

Phase 2 Recruiting
36 enrolled
Gastrointestinal

Bile Duct Neoplasms

NCT04450758 2026-04-23

ACBC

Skane University Hospital

Recruiting
1,000 enrolled
Gastrointestinal

Colonic Neoplasms

NCT06630910 2026-03-31

whipple

Theodor Bilharz Research Institute

Phase NA Completed
48 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡